As expected, we also observed a dose-dependent decrease in other downstream oncoproteins involved in breast cancer cell migration, invasion, and cell cycle progression such as WNK1 (kinase with no lysine (K) 1) (45, 46), and Cyclin-D1 (47, 48), respectively (Figure 3D). Here, CCND1 is linked to breast carcinoma.